N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients
Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effect of N-acetyl cysteine in combination with
paclitaxel on the clinical outcomes of patients with peripheral neuropathy,
paclitaxel-induced peripheral neuropathy affect quality of life in cancer patients.
new therapeutic approches such as the antioxidant N-acetyl cysteine, showed to has
neuroprotective effect, the aim of the study is to evaluate the effect of N-
acetylcysteine(NAC) administration in the prevention of paclitaxel-Induced peripheral
neuropathy.